search
Back to results

Modified ABC: A Home-based Parenting Program for Opioid-dependent Mothers and Their Infants (mABC)

Primary Purpose

Opioid-Related Disorders, Parent-Child Relations, Infant Development

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Modified Attachment and Biobehavioral Catch-up
Modified Developmental Education for Families
Sponsored by
University of Delaware
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Opioid-Related Disorders

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • In third trimester of pregnancy or up to one month postpartum
  • Receiving medication-assisted treatment for opioid use disorder

Exclusion Criteria:

  • None

Sites / Locations

  • University of Delaware

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Modified ABC

Modified DEF

Arm Description

Modified Attachment and Biobehavioral Catch-Up (14 session in-home intervention with parents and infants present) and Safe Environment for Every Kid (1 to 2 in-home resource visits)

Modified Developmental Education for Families (14 session in-home intervention with parents and infants present) and Safe Environment for Every Kid (1 to 2 in-home resource visits)

Outcomes

Primary Outcome Measures

Maternal sensitivity
Maternal sensitivity will be coded observationally from maternal interactions with an infant simulator pre-programmed to coo and then cry. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.
Maternal sensitivity
Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.
Maternal sensitivity
Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.
Maternal sensitivity
Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.
Maternal methylation of μ-opioid receptor (OPRM1) gene
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Maternal methylation of μ-opioid receptor (OPRM1) gene
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Maternal methylation of μ-opioid receptor (OPRM1) gene
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Maternal methylation of μ-opioid receptor (OPRM1) gene
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Maternal methylation of oxytocin receptor (OXTR) gene
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Maternal methylation of oxytocin receptor (OXTR) gene
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Maternal methylation of oxytocin receptor (OXTR) gene
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Maternal methylation of oxytocin receptor (OXTR) gene
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Infant methylation of μ-opioid receptor (OPRM1) gene
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Infant methylation of μ-opioid receptor (OPRM1) gene
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Infant methylation of μ-opioid receptor (OPRM1) gene
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Infant methylation of oxytocin receptor (OXTR) gene
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Infant methylation of oxytocin receptor (OXTR) gene
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Infant methylation of oxytocin receptor (OXTR) gene
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Maternal neural activity (EEG) - Own child-other child task
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing photos of their own infants, familiar infants, and unfamiliar infants.
Maternal neural activity (EEG) - Own child-other child task
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing photos of their own infants, familiar infants, and unfamiliar infants.
Maternal neural activity (EEG) - Reward sensitivity task
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images.
Maternal neural activity (EEG) - Reward sensitivity task
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images.
Maternal neural activity (EEG) - Child emotion task
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images of children crying, laughing, and showing neutral expressions.
Maternal neural activity (EEG) - Child emotion task
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images of children crying, laughing, and showing neutral expressions.
Maternal parasympathetic nervous system activity
Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Maternal sympathetic nervous system activity
Maternal sympathetic nervous system activity will be assessed using pre-ejection period.
Maternal parasympathetic nervous system activity
Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Maternal sympathetic nervous system activity
Maternal sympathetic nervous system activity will be assessed using pre-ejection period.
Maternal parasympathetic nervous system activity
Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Maternal sympathetic nervous system activity
Maternal sympathetic nervous system activity will be assessed using pre-ejection period.
Maternal parasympathetic nervous system activity
Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Maternal sympathetic nervous system activity
Maternal sympathetic nervous system activity will be assessed using pre-ejection period.
Infant parasympathetic nervous system activity
Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Infant sympathetic nervous system activity
Infant sympathetic nervous system activity will be assessed using pre-ejection period.
Infant parasympathetic nervous system activity
Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Infant sympathetic nervous system activity
Infant sympathetic nervous system activity will be assessed using pre-ejection period.
Infant parasympathetic nervous system activity
Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Infant sympathetic nervous system activity
Infant sympathetic nervous system activity will be assessed using pre-ejection period.
Maternal diurnal cortisol production
Maternal diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Maternal diurnal cortisol production
Maternal diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Infant diurnal cortisol production
Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Infant diurnal cortisol production
Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Infant diurnal cortisol production
Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Infant behavioral regulation - Still Face Paradigm
Behavioral coding of emotion reactivity and regulation will be conducted from video recordings of the Still Face Paradigm, a mild social stressor.
Infant behavioral regulation - Arm Restraint Task
Behavioral coding of emotion reactivity and regulation will be conducted from video recordings of the Arm Restraint Task, a mild stressor.
Infant attachment
Infant attachment will be assessed using the Strange Situation.
Infant cognitive development
Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.
Infant motor development
Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.
Infant social-emotional development
Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.
Infant cognitive development
Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.
Infant motor development
Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.
Infant social-emotional development
Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.
Infant cognitive development
Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.
Infant motor development
Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.
Infant social-emotional development
Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.
Infant social-emotional problems
Infant social-emotional problems will be assessed through maternal report on the Brief Infant-Toddler Social Emotional Assessment.
Maternal self-efficacy
Mothers will report on their parenting self-efficacy using the Maternal Self-Efficacy Scale. Mothers will rate their self-efficacy for each of ten items (nine discrete parenting behaviors and one global parenting item) on a 4-point scale from 1-not good at all to 4-very good. Scores are summed to form a total maternal self-efficacy composite (possible range = 10-40), where higher scores indicated more maternal self-efficacy.
Maternal self-efficacy
Mothers will report on their parenting self-efficacy using the Maternal Self-Efficacy Scale. Mothers will rate their self-efficacy for each of ten items (nine discrete parenting behaviors and one global parenting item) on a 4-point scale from 1-not good at all to 4-very good. Scores are summed to form a total maternal self-efficacy composite (possible range = 10-40), where higher scores indicated more maternal self-efficacy.
Maternal emotion regulation
Mothers will report on their emotion regulation using the Difficulties with Emotion Regulation Scale - Short Form (DERS-SF). The DERS-SF consists of 18 items rated on a scale from 1-almost never to 5-almost always. The DERS-SF yields six subscales (strategies, non-acceptance, impulse, goals, awareness, and clarity), each of which range from 3 to 15, and one total score, which ranges from 18 to 90. Higher scores indicate greater emotion dysregulation.
Maternal emotion regulation
Mothers will report on their emotion regulation using the Difficulties with Emotion Regulation Scale - Short Form (DERS-SF). The DERS-SF consists of 18 items rated on a scale from 1-almost never to 5-almost always. The DERS-SF yields six subscales (strategies, non-acceptance, impulse, goals, awareness, and clarity), each of which range from 3 to 15, and one total score, which ranges from 18 to 90. Higher scores indicate greater emotion dysregulation.

Secondary Outcome Measures

Maternal substance use - interview
The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.
Maternal substance use - interview
The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.
Maternal substance use - interview
The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.
Maternal substance use - questionnaire
Mothers will report their history of substance use using the NIDA ASSIST questionnaire.
Maternal substance use - questionnaire
Mothers will report recent substance use using the NIDA Quick Screen questionnaire.
Maternal substance use - questionnaire
Mothers will report recent substance use using the NIDA Quick Screen questionnaire.
Maternal substance use - questionnaire
Mothers will report recent substance use using the NIDA Quick Screen questionnaire.
Maternal depressive symptoms
Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.
Maternal depressive symptoms
Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.
Maternal depressive symptoms
Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.
Maternal depressive symptoms
Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.
Infant physical growth
Infant physical growth will be assessed using weight, length, and head circumference.
Infant physical growth
Infant physical growth will be assessed using weight, length, and head circumference.
Infant physical growth
Infant physical growth will be assessed using weight, length, and head circumference.
Maternal experiences during labor and delivery
Mothers will report on their experiences during labor and delivery using the Birth Satisfaction Scale-Revised questionnaire (BSS-R). This measure consists of ten items rated on a 5-point scale from 1-Strongly Disagree to 5-Strongly Agree. The total score ranges from 10-50, where higher scores represent more birth satisfaction.
Home environment
The home environment will be assessed using the Cognitive Stimulation subscale of the HOME Short Form, a combination of observation (two items) and maternal report (seven items). Observation items are binary (yes/no), and mother-report items are rated on a Likert-type scale and dichotomized. Dichotomous items are summed to form a total score (range 0-9), with higher scores indicating more cognitive stimulation.
Maternal reward responsiveness
Mothers will report their reward responsiveness using the Reward Responsiveness Scale. This is an 8-item scale rated on a 4-point scale from 1-Strong Disagreement to 4-Strong Agreement. The total score ranges from 8 to 32, with higher scores representing greater reward responsiveness.
Maternal reward responsiveness
Mothers will report their reward responsiveness using the Reward Responsiveness Scale. This is an 8-item scale rated on a 4-point scale from 1-Strong Disagreement to 4-Strong Agreement. The total score ranges from 8 to 32, with higher scores representing greater reward responsiveness.
Maternal sleep
Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.
Maternal sleep
Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.
Maternal sleep
Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.
Maternal sleep
Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.
Infant sleep
Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.
Infant sleep
Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.
Infant sleep
Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.

Full Information

First Posted
February 21, 2019
Last Updated
August 30, 2021
Sponsor
University of Delaware
search

1. Study Identification

Unique Protocol Identification Number
NCT03891628
Brief Title
Modified ABC: A Home-based Parenting Program for Opioid-dependent Mothers and Their Infants
Acronym
mABC
Official Title
Modified Attachment and Biobehavioral Catch-Up for Mothers and Their Infants
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
August 13, 2018 (Actual)
Primary Completion Date
March 31, 2021 (Actual)
Study Completion Date
March 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Delaware

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will assess the efficacy of the modified Attachment and Biobehavioral Catch-Up Intervention, adapted for use with peripartum mothers receiving medication-assisted treatment for opioid use disorder. The investigators expect that mothers who receive the modified Attachment and Biobehavioral Catch-up Intervention will show more nurturing and sensitive parenting and more adaptive physiological regulation than parents who receive a control intervention. The investigators expect that infants whose mothers receive the modified Attachment and Biobehavioral Catch-up will show better outcomes in attachment, behavior, and physiological regulation compared to infants of parents who receive the control intervention.
Detailed Description
Peripartum mothers will be randomly assigned to receive the modified ABC intervention or the control intervention (modified DEF). Hypotheses relate to parent and child outcomes associated with the intervention. Hypothesis 1: Compared to mothers who receive the control intervention, mothers who receive the ABC intervention will show more nurturing and sensitive parenting, enhanced neural activity during parenting-relevant tasks, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production. Hypothesis 2: Compared to infants of mothers who receive the control intervention, infants of mothers who receive the ABC intervention will show more organized and secure attachment patterns, better behavioral regulation during stressors, more advanced social-emotional development, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production. Hypothesis 3: Enhanced maternal sensitivity will mediate effects of the ABC intervention on improved infant outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid-Related Disorders, Parent-Child Relations, Infant Development, Parenting

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
65 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Modified ABC
Arm Type
Experimental
Arm Description
Modified Attachment and Biobehavioral Catch-Up (14 session in-home intervention with parents and infants present) and Safe Environment for Every Kid (1 to 2 in-home resource visits)
Arm Title
Modified DEF
Arm Type
Active Comparator
Arm Description
Modified Developmental Education for Families (14 session in-home intervention with parents and infants present) and Safe Environment for Every Kid (1 to 2 in-home resource visits)
Intervention Type
Behavioral
Intervention Name(s)
Modified Attachment and Biobehavioral Catch-up
Other Intervention Name(s)
mABC
Intervention Description
Intervention targets include enhancing nurturance and following the child's lead, as well as supporting use of kangaroo care, swaddling, and breastfeeding.
Intervention Type
Behavioral
Intervention Name(s)
Modified Developmental Education for Families
Other Intervention Name(s)
mDEF
Intervention Description
Intervention targets include supporting developmental monitoring and parental engagement in activities that promote cognitive and motor development.
Primary Outcome Measure Information:
Title
Maternal sensitivity
Description
Maternal sensitivity will be coded observationally from maternal interactions with an infant simulator pre-programmed to coo and then cry. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal sensitivity
Description
Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.
Time Frame
Infant age 3 months
Title
Maternal sensitivity
Description
Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.
Time Frame
Infant age 6 months
Title
Maternal sensitivity
Description
Maternal sensitivity will be coded observationally from mother-infant play interactions, in which mothers will be given toys and asked to play as they normally would. Mothers will be coded for sensitivity, nurturance, intrusiveness, detachment, and positive regard, on 5 point scales from 1-Not at all characteristic to 5-Highly characteristic. Higher scores on sensitivity, nurturance, and positive regard represent more positive parenting, whereas higher scores on nurturance and detachment represent less positive parenting.
Time Frame
Infant age 12 months
Title
Maternal methylation of μ-opioid receptor (OPRM1) gene
Description
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal methylation of μ-opioid receptor (OPRM1) gene
Description
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 3 months
Title
Maternal methylation of μ-opioid receptor (OPRM1) gene
Description
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 6 months
Title
Maternal methylation of μ-opioid receptor (OPRM1) gene
Description
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 12 months
Title
Maternal methylation of oxytocin receptor (OXTR) gene
Description
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal methylation of oxytocin receptor (OXTR) gene
Description
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 3 months
Title
Maternal methylation of oxytocin receptor (OXTR) gene
Description
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 6 months
Title
Maternal methylation of oxytocin receptor (OXTR) gene
Description
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 12 months
Title
Infant methylation of μ-opioid receptor (OPRM1) gene
Description
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 3 months
Title
Infant methylation of μ-opioid receptor (OPRM1) gene
Description
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 6 months
Title
Infant methylation of μ-opioid receptor (OPRM1) gene
Description
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 12 months
Title
Infant methylation of oxytocin receptor (OXTR) gene
Description
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 3 months
Title
Infant methylation of oxytocin receptor (OXTR) gene
Description
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 6 months
Title
Infant methylation of oxytocin receptor (OXTR) gene
Description
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva.
Time Frame
Infant age 12 months
Title
Maternal neural activity (EEG) - Own child-other child task
Description
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing photos of their own infants, familiar infants, and unfamiliar infants.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal neural activity (EEG) - Own child-other child task
Description
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing photos of their own infants, familiar infants, and unfamiliar infants.
Time Frame
Infant age 12 months
Title
Maternal neural activity (EEG) - Reward sensitivity task
Description
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal neural activity (EEG) - Reward sensitivity task
Description
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images.
Time Frame
Infant age 12 months
Title
Maternal neural activity (EEG) - Child emotion task
Description
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images of children crying, laughing, and showing neutral expressions.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal neural activity (EEG) - Child emotion task
Description
Maternal event-related potentials will be assessed using electroencephalogram (EEG) while viewing images of children crying, laughing, and showing neutral expressions.
Time Frame
Infant age 12 months
Title
Maternal parasympathetic nervous system activity
Description
Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal sympathetic nervous system activity
Description
Maternal sympathetic nervous system activity will be assessed using pre-ejection period.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal parasympathetic nervous system activity
Description
Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Time Frame
Infant age 3 months
Title
Maternal sympathetic nervous system activity
Description
Maternal sympathetic nervous system activity will be assessed using pre-ejection period.
Time Frame
Infant age 3 months
Title
Maternal parasympathetic nervous system activity
Description
Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Time Frame
Infant age 6 months
Title
Maternal sympathetic nervous system activity
Description
Maternal sympathetic nervous system activity will be assessed using pre-ejection period.
Time Frame
Infant age 6 months
Title
Maternal parasympathetic nervous system activity
Description
Maternal parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Time Frame
Infant age 12 months
Title
Maternal sympathetic nervous system activity
Description
Maternal sympathetic nervous system activity will be assessed using pre-ejection period.
Time Frame
Infant age 12 months
Title
Infant parasympathetic nervous system activity
Description
Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Time Frame
Infant age 3 months
Title
Infant sympathetic nervous system activity
Description
Infant sympathetic nervous system activity will be assessed using pre-ejection period.
Time Frame
Infant age 3 months
Title
Infant parasympathetic nervous system activity
Description
Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Time Frame
Infant age 6 months
Title
Infant sympathetic nervous system activity
Description
Infant sympathetic nervous system activity will be assessed using pre-ejection period.
Time Frame
Infant age 6 months
Title
Infant parasympathetic nervous system activity
Description
Infant parasympathetic nervous system activity will be assessed using respiratory sinus arrhythmia.
Time Frame
Infant age 12 months
Title
Infant sympathetic nervous system activity
Description
Infant sympathetic nervous system activity will be assessed using pre-ejection period.
Time Frame
Infant age 12 months
Title
Maternal diurnal cortisol production
Description
Maternal diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal diurnal cortisol production
Description
Maternal diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Time Frame
Infant age 12 months
Title
Infant diurnal cortisol production
Description
Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Time Frame
Infant age 3 months
Title
Infant diurnal cortisol production
Description
Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Time Frame
Infant age 6 months
Title
Infant diurnal cortisol production
Description
Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at wake-time and bed-time.
Time Frame
Infant age 12 months
Title
Infant behavioral regulation - Still Face Paradigm
Description
Behavioral coding of emotion reactivity and regulation will be conducted from video recordings of the Still Face Paradigm, a mild social stressor.
Time Frame
Infant age 6 months
Title
Infant behavioral regulation - Arm Restraint Task
Description
Behavioral coding of emotion reactivity and regulation will be conducted from video recordings of the Arm Restraint Task, a mild stressor.
Time Frame
Infant age 12 months
Title
Infant attachment
Description
Infant attachment will be assessed using the Strange Situation.
Time Frame
Infant age 12 months
Title
Infant cognitive development
Description
Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.
Time Frame
Infant age 3 months
Title
Infant motor development
Description
Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.
Time Frame
Infant age 3 months
Title
Infant social-emotional development
Description
Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.
Time Frame
Infant age 3 months
Title
Infant cognitive development
Description
Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.
Time Frame
Infant age 6 months
Title
Infant motor development
Description
Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.
Time Frame
Infant age 6 months
Title
Infant social-emotional development
Description
Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.
Time Frame
Infant age 6 months
Title
Infant cognitive development
Description
Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire.
Time Frame
Infant age 12 months
Title
Infant motor development
Description
Infant motor development will be assessed through maternal report on the Ages and Stages Questionnaire.
Time Frame
Infant age 12 months
Title
Infant social-emotional development
Description
Infant social-emotional development will be assessed through maternal report on the Ages and Stages Questionnaire: Social-Emotional.
Time Frame
Infant age 12 months
Title
Infant social-emotional problems
Description
Infant social-emotional problems will be assessed through maternal report on the Brief Infant-Toddler Social Emotional Assessment.
Time Frame
Infant age 12 months
Title
Maternal self-efficacy
Description
Mothers will report on their parenting self-efficacy using the Maternal Self-Efficacy Scale. Mothers will rate their self-efficacy for each of ten items (nine discrete parenting behaviors and one global parenting item) on a 4-point scale from 1-not good at all to 4-very good. Scores are summed to form a total maternal self-efficacy composite (possible range = 10-40), where higher scores indicated more maternal self-efficacy.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal self-efficacy
Description
Mothers will report on their parenting self-efficacy using the Maternal Self-Efficacy Scale. Mothers will rate their self-efficacy for each of ten items (nine discrete parenting behaviors and one global parenting item) on a 4-point scale from 1-not good at all to 4-very good. Scores are summed to form a total maternal self-efficacy composite (possible range = 10-40), where higher scores indicated more maternal self-efficacy.
Time Frame
Infant age 12 months
Title
Maternal emotion regulation
Description
Mothers will report on their emotion regulation using the Difficulties with Emotion Regulation Scale - Short Form (DERS-SF). The DERS-SF consists of 18 items rated on a scale from 1-almost never to 5-almost always. The DERS-SF yields six subscales (strategies, non-acceptance, impulse, goals, awareness, and clarity), each of which range from 3 to 15, and one total score, which ranges from 18 to 90. Higher scores indicate greater emotion dysregulation.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal emotion regulation
Description
Mothers will report on their emotion regulation using the Difficulties with Emotion Regulation Scale - Short Form (DERS-SF). The DERS-SF consists of 18 items rated on a scale from 1-almost never to 5-almost always. The DERS-SF yields six subscales (strategies, non-acceptance, impulse, goals, awareness, and clarity), each of which range from 3 to 15, and one total score, which ranges from 18 to 90. Higher scores indicate greater emotion dysregulation.
Time Frame
Infant age 12 months
Secondary Outcome Measure Information:
Title
Maternal substance use - interview
Description
The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal substance use - interview
Description
The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.
Time Frame
Infant age 6 months
Title
Maternal substance use - interview
Description
The Timeline Followback Interview will be used to assess maternal use of opioids, tobacco, alcohol, marijuana, and other substances.
Time Frame
Infant age 12 months
Title
Maternal substance use - questionnaire
Description
Mothers will report their history of substance use using the NIDA ASSIST questionnaire.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal substance use - questionnaire
Description
Mothers will report recent substance use using the NIDA Quick Screen questionnaire.
Time Frame
Infant age 3 months
Title
Maternal substance use - questionnaire
Description
Mothers will report recent substance use using the NIDA Quick Screen questionnaire.
Time Frame
Infant age 6 months
Title
Maternal substance use - questionnaire
Description
Mothers will report recent substance use using the NIDA Quick Screen questionnaire.
Time Frame
Infant age 12 months
Title
Maternal depressive symptoms
Description
Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal depressive symptoms
Description
Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.
Time Frame
Infant age 3 months
Title
Maternal depressive symptoms
Description
Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.
Time Frame
Infant age 6 months
Title
Maternal depressive symptoms
Description
Maternal depressive symptoms will be self-reported using the Beck Depression Inventory.
Time Frame
Infant age 12 months
Title
Infant physical growth
Description
Infant physical growth will be assessed using weight, length, and head circumference.
Time Frame
Infant age 3 months
Title
Infant physical growth
Description
Infant physical growth will be assessed using weight, length, and head circumference.
Time Frame
Infant age 6 months
Title
Infant physical growth
Description
Infant physical growth will be assessed using weight, length, and head circumference.
Time Frame
Infant age 12 months
Title
Maternal experiences during labor and delivery
Description
Mothers will report on their experiences during labor and delivery using the Birth Satisfaction Scale-Revised questionnaire (BSS-R). This measure consists of ten items rated on a 5-point scale from 1-Strongly Disagree to 5-Strongly Agree. The total score ranges from 10-50, where higher scores represent more birth satisfaction.
Time Frame
Infant age 3 months
Title
Home environment
Description
The home environment will be assessed using the Cognitive Stimulation subscale of the HOME Short Form, a combination of observation (two items) and maternal report (seven items). Observation items are binary (yes/no), and mother-report items are rated on a Likert-type scale and dichotomized. Dichotomous items are summed to form a total score (range 0-9), with higher scores indicating more cognitive stimulation.
Time Frame
Infant age 3 months
Title
Maternal reward responsiveness
Description
Mothers will report their reward responsiveness using the Reward Responsiveness Scale. This is an 8-item scale rated on a 4-point scale from 1-Strong Disagreement to 4-Strong Agreement. The total score ranges from 8 to 32, with higher scores representing greater reward responsiveness.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal reward responsiveness
Description
Mothers will report their reward responsiveness using the Reward Responsiveness Scale. This is an 8-item scale rated on a 4-point scale from 1-Strong Disagreement to 4-Strong Agreement. The total score ranges from 8 to 32, with higher scores representing greater reward responsiveness.
Time Frame
Infant age 12 months
Title
Maternal sleep
Description
Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.
Time Frame
Pre-intervention (third trimester of gestation or up to one month postpartum)
Title
Maternal sleep
Description
Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.
Time Frame
Infant age 3 months
Title
Maternal sleep
Description
Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.
Time Frame
Infant age 6 months
Title
Maternal sleep
Description
Mothers will report on their sleep habits using the Pittsburgh Sleep Quality Index.
Time Frame
Infant age 12 months
Title
Infant sleep
Description
Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.
Time Frame
Infant age 3 months
Title
Infant sleep
Description
Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.
Time Frame
Infant age 6 months
Title
Infant sleep
Description
Mothers will report on their infant's sleep habits using the Brief Infant Sleep Questionnaire.
Time Frame
Infant age 12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: In third trimester of pregnancy or up to one month postpartum Receiving medication-assisted treatment for opioid use disorder Exclusion Criteria: None
Facility Information:
Facility Name
University of Delaware
City
Newark
State/Province
Delaware
ZIP/Postal Code
19716
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35748625
Citation
Tabachnick AR, Eiden RD, Labella MH, Dozier M. Effects of an attachment-based intervention on autonomic regulation among opioid-exposed infants. Dev Psychobiol. 2022 Sep;64(6):e22286. doi: 10.1002/dev.22286.
Results Reference
derived

Learn more about this trial

Modified ABC: A Home-based Parenting Program for Opioid-dependent Mothers and Their Infants

We'll reach out to this number within 24 hrs